pharma news, views and analysis

in Oncology
Cancer, genomics and personalised medicine: Modelling the future of oncology
December 4, 2018 Share
X
Cancer, genomics and personalised medicine: Modelling the future of oncology
https://pharmaphorum.com/oncology/cancer-genomics-and-personalised-medicine-modelling-the-future-of-oncology/
in Sales and Marketing
Metrics to meaning: demonstrating the value of medical communications
November 14, 2018 Share
X
Metrics to meaning: demonstrating the value of medical communications
https://pharmaphorum.com/sales-marketing/metrics-to-meaning-demonstrating-the-value-of-medical-communications/
in News
NICE reveals new standards for digital tech
December 11, 2018 Share
X
NICE reveals new standards for digital tech
https://pharmaphorum.com/news/nice-reveals-new-standards-for-digital-tech/
in News
Generics firms the ‘biggest cartel in US history’ – report
December 11, 2018 Share
X
Generics firms the ‘biggest cartel in US history’ – report
https://pharmaphorum.com/news/generics-firms-the-biggest-cartel-in-us-history-report/
in Sales and Marketing
How to make pharma marketing content unskippable
December 11, 2018 Share
X
How to make pharma marketing content unskippable
https://pharmaphorum.com/sales-marketing/how-to-make-pharma-marketing-content-unskippable/
in Views & Analysis
Dutch biotech Pharming plans to challenge big pharma in rare diseases
December 10, 2018 Share
X
Dutch biotech Pharming plans to challenge big pharma in rare diseases
https://pharmaphorum.com/r-d/views-analysis-r-d/pharming-challenge-pharma-rare-diseases/

Latest News

Akorn searches for new CEO after failed Fresenius merger

US generics firm Akorn is searching for a new CEO in the wake of a failed merger with

Akorn searches for new CEO after failed Fresenius merger

https://pharmaphorum.com/news/akorn-searches-for-new-ceo-after-failed-fresenius-merger/

Certain brain tumours could respond to immunotherapy

Some brain tumours may respond to immunotherapy after all, according to a new study. So far, brain tumours

Certain brain tumours could respond to immunotherapy

https://pharmaphorum.com/news/certain-brain-tumours-could-respond-to-immunotherapy/

Boehringer follows Sanofi with job cuts in France

Boehringer Ingelheim has confirmed it plans to axe more than 10% of its workforce in France, or more

Boehringer follows Sanofi with job cuts in France

https://pharmaphorum.com/news/boehringer-follows-sanofi-with-job-cuts-in-france/

See all

Views & analysis

Digital health round-up: Market worth $379bn and still growing

Richard Staines presents his weekly round-up of the digital health news headlines

Digital health round-up: Market worth $379bn and still growing

https://pharmaphorum.com/views-and-analysis/digital-health-round-up-market-worth-379bn-and-still-growing/

Four steps for more patient centric trials

Medidata’s general manager & senior vice president EMEA, Christian Hebenstreit, on placing the patient experience at the heart

Four steps for more patient centric trials

https://pharmaphorum.com/r-d/views-analysis-r-d/four-steps-patient-centric-trials/

Insight, market monitoring and assessing whether a brand plan is fit for purpose

This article is the last in a series of three from Osprey Health Consulting. In this third article

Insight, market monitoring and assessing whether a brand plan is fit for purpose

https://pharmaphorum.com/views-analysis-sales-marketing/insight-market-monitoring-and-assessing-whether-a-brand-plan-is-fit-for-purpose/

See all

Deep Dive Magazine

European digital health innovation

Healthcare and the pharmaceutical industry are redefining their roles for the modern age as digital health tech radically

European digital health innovation

https://pharmaphorum.com/digital/european-digital-health-innovation/

CAR-Ts – a new weapon in the fight against cancer

CAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies

CAR-Ts – a new weapon in the fight against cancer

https://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/

How to achieve digital success in pharma’s communications

Demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for

How to achieve digital success in pharma’s communications

https://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/

See all

Webinars

Cancer, genomics and personalised medicine: Modelling the future of oncology

https://pharmaphorum.com/oncology/cancer-genomics-and-personalised-medicine-modelling-the-future-of-oncology/

Metrics to meaning: demonstrating the value of medical communications

https://pharmaphorum.com/sales-marketing/metrics-to-meaning-demonstrating-the-value-of-medical-communications/

The devil’s in the e-detail: what HCPs really want from you

https://pharmaphorum.com/digital/the-devils-in-the-e-detail-what-hcps-really-want-from-you/

See all

White papers

Adherence – Don’t Remind Me!

The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course

Adherence – Don’t Remind Me!

https://pharmaphorum.com/sales-marketing/adherence-dont-remind-me/

Intelligent HCP engagement in Europe – what do doctors want?

The opportunity to engage with HCPs digitally has never been more prevalent. We are witnessing a desire from

Intelligent HCP engagement in Europe – what do doctors want?

https://pharmaphorum.com/digital/intelligent-hcp-engagement-europe/

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

See all

Video

Commercialising orphan drugs: the pharmaphorum podcast

https://pharmaphorum.com/r-d/views-analysis-r-d/orphan-drugs-pharmaphorum-podcast/

The future of pharma in a digital world

https://pharmaphorum.com/digital/healthlive-the-future-of-pharma-in-a-digital-world/

Raising the bar in liver cancer therapy

https://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/

See all

Partner content

Press releases

Hear from PFS industry leaders from big pharma & government bodies

https://pharmaphorum.com/partner-content/hear-from-pfs-industry-leaders-from-big-pharma-government-bodies/

Invite from James Drinkwater Chairing 2nd Annual Pharmaceutical Microbiology East Coast

https://pharmaphorum.com/partner-content/invite-from-james-drinkwater-chairing-2nd-annual-pharmaceutical-microbiology-east-coast/

The Strategies to Reach Out and Engage with Your Customers

https://pharmaphorum.com/partner-content/the-strategies-to-reach-out-and-engage-with-your-customers/

Registration opens for the 11th Adaptive Designs in Clinical Trials

https://pharmaphorum.com/partner-content/registration-opens-for-the-11th-adaptive-designs-in-clinical-trials/

See all

Appointments

pharmaphorum welcomes George Underwood to its editorial helm

https://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/

STEM Healthcare appoints Jason McKenna as CEO

https://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/

See all

Search

Advanced Search

Trending

Press releases

Appointments